Is BNGO expected to rise?

Is BNGO expected to rise?

Bionano Genomics Inc (NASDAQ:BNGO)

The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +262.32% increase from the last price of 2.07.

Similarly, Who owns Bionano genomics?

Top 10 Owners of Bionano Genomics Inc

Stockholder Stake Shares owned
BlackRock Fund Advisors 5.74% 16,609,007
The Vanguard Group, Inc. 4.86% 14,064,639
SSgA Funds Management, Inc. 2.49% 7,198,880
Geode Capital Management LLC 1.63% 4,714,883

Should I invest in BNGO stock? The financial health and growth prospects of BNGO, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of F.

Thereof, What is Nio price target?

The 29 analysts offering 12-month price forecasts for NIO Inc have a median target of 32.94, with a high estimate of 86.57 and a low estimate of 24.08. The median estimate represents a +67.62% increase from the last price of 19.65.

What kind of stock is BNGO?

Key Data

Label Value
Sector Capital Goods
Industry Biotechnology: Laboratory Analytical Instruments
1 Year Target $10.00
Today’s High/Low $2.18/$2.07

Where is BNGO located?

The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

What institutions are buying NIO?

Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …

What institutions are buying BNGO?

Bionano Genomics (NASDAQ:BNGO) Institutional Buying and Selling

Reporting Date Hedge Fund Ownership in Company
2/14/2022 Nuveen Asset Management LLC 0.357%
2/14/2022 Barclays PLC 0.123%
2/14/2022 GSA Capital Partners LLP 0.019%
2/14/2022 Mutual Advisors LLC 0.017%

Is Bionano overvalued?

From Wall Street analysts, BNGO earns a Strong Buy analyst consensus based on 4 Buy ratings in the past 3 months. Additionally, the average analyst BioNano price target of $11.50 puts the upside potential at 58.62%.

What does BNGO company do?

Company Description

The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.

How popular is Nio in China?

Shanghai-based Nio was founded in 2014 by William Li, a billionaire entrepreneur who got rich selling services to the auto industry. Nio currently sells three models and has a fourth on the way for early 2022. It’s delivered some 140,000 cars to customers in China and is expanding to Europe.

Who owns the most Nio stock?

Top 10 Owners of NIO Inc

Stockholder Stake Shares owned
Baillie Gifford & Co. 5.76% 88,858,365
BlackRock Fund Advisors 2.60% 40,093,147
The Vanguard Group, Inc. 2.40% 36,994,474
SSgA Funds Management, Inc. 2.13% 32,887,731

What is a good price for Nio?

NIO Price/Volume Stats

Current price $19.65 52-week high
Day low $19.53 Volume
Day high $20.40 Avg. volume
50-day MA $21.26 Dividend yield
200-day MA $33.25 Market Cap

How many shares does BNGO have?

BioNano Genomics Inc (US:BNGO) has 292 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,218,166 shares.

What is the short interest in BNGO?

Bionano Genomics currently has a short interest ratio of 5.0.

How many outstanding shares does BNGO have?

Share Statistics

Avg Vol (3 month) 3 8.16M
Shares Outstanding 5 289.61M
Implied Shares Outstanding 6 N/A
Float 8 283.64M
% Held by Insiders 1 2.17%

What sector is BNGO stock?

Key Data

Label Value
Sector Capital Goods
Industry Biotechnology: Laboratory Analytical Instruments
1 Year Target $11.00
Today’s High/Low $2.77/$2.57

What kind of company is Bionano genomics?

Bionano Genomics, Inc. provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents.

Who owns the most stock in NIO?

Top 10 Owners of NIO Inc

Stockholder Stake Shares owned
BlackRock Fund Advisors 2.99% 40,093,147
The Vanguard Group, Inc. 2.76% 36,994,474
SSgA Funds Management, Inc. 2.45% 32,887,731
Goldman Sachs & Co. LLC (Private … 1.73% 23,202,778

Did BlackRock buy NIO stock?

2022-02-10 – BlackRock Inc. has filed a 13F-HR form disclosing ownership of 64,036,975 shares of Nio Inc (US:NIO) with total holdings valued at $2,028,693,000 USD as of 2021-12-31.

What percent of NIO is public?

Public Company Ownership

Public companies currently own 8.5% of NIO stock. It’s hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it’s worth watching this space for changes in ownership.

Join TheMoney.co community and don’t forget to share this post !

Quitter la version mobile